{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:16:32Z","timestamp":1793661392855,"version":"4.5.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bja.2024.05.046","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T21:21:55Z","timestamp":1722892915000},"page":"759-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8898-6772","authenticated-orcid":false,"given":"Carlos A.","family":"Ibarra Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9372-7019","authenticated-orcid":false,"given":"Helga C.A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7735-3267","authenticated-orcid":false,"given":"Luuk R.","family":"van den Bersselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rendu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0819-4885","authenticated-orcid":false,"given":"Agnieszka","family":"Cieniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8127-1739","authenticated-orcid":false,"given":"Philip M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0670-1516","authenticated-orcid":false,"given":"Sheila","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2024.05.046_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bja.2023.04.014","article-title":"What is malignant hyperthermia susceptibility?","volume":"131","author":"Hopkins","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/bja\/aep204","article-title":"Genetic variation in RYR1 and malignant hyperthermia phenotypes","volume":"103","author":"Carpenter","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/ALN.0000000000000732","article-title":"Malignant hyperthermia testing in probands without adverse anesthetic reaction","volume":"123","author":"Timmins","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.05.046_bib6","first-page":"1504","article-title":"A\u00a0novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"260","author":"L\u00f8seth","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.bja.2024.05.046_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nmd.2015.01.016","article-title":"A\u00a0novel large deletion in the RYR1 gene in a Belgian family with late-onset and recessive core myopathy","volume":"25","author":"Remiche","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2024.05.046_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/mgg3.338","article-title":"RYR1 causing distal myopathy","volume":"5","author":"Laughlin","year":"2017","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.bja.2024.05.046_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","article-title":"Malignant hyperthermia susceptibility and related diseases","volume":"128","author":"Litman","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.05.046_bib10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/ene.12713","article-title":"RYR1-related myopathies: a wide spectrum of phenotypes throughout life","volume":"22","author":"Snoeck","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bja.2024.05.046_bib11","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1212\/NXG.0000000000000341","article-title":"Congenital myopathies in the adult neuromuscular clinic: diagnostic challenges and pitfalls","volume":"5","author":"Nicolau","year":"2019","journal-title":"Neurol Genet"},{"key":"10.1016\/j.bja.2024.05.046_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac292","article-title":"Neuromuscular symptoms in patients with RYR1-related malignant hyperthermia and rhabdomyolysis","volume":"4","author":"van den Bersselaar","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.bja.2024.05.046_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/ane.12885","article-title":"Phenotype and genotype of muscle ryanodine receptor rhabdomyolysis\u2013myalgia syndrome","volume":"137","author":"Witting","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bja.2024.05.046_bib14","first-page":"569","article-title":"Oral dantrolene for myopathic symptoms in malignant hyperthermia-susceptible patients: a 25-year retrospective cohort study of adverse effects and tolerability","volume":"136","author":"Ibarra Moreno","year":"2023","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.05.046_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archneur.61.1.106","article-title":"Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in\u00a0vitro contracture tests, and genetic characterization","volume":"61","author":"Guis","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bja.2024.05.046_bib16","first-page":"235","article-title":"Late-onset myopathies: clinical features and diagnosis","volume":"39","author":"de Visser","year":"2020","journal-title":"Acta Myol"},{"key":"10.1016\/j.bja.2024.05.046_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.nmd.2023.09.007","article-title":"Recurrent atraumatic compartment syndrome as a manifestation of genetic neuromuscular disease","volume":"33","author":"Famili","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2024.05.046_bib19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain\u2013Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bja.2024.05.046_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2024.05.046_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12630-017-0865-5","article-title":"Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review","volume":"64","author":"Kraeva","year":"2017","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.nmd.2022.06.003","article-title":"Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH)","volume":"32","author":"Riazi","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2024.05.046_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.286.2.168","article-title":"Malignant hyperthermia and apparent heat stroke","volume":"286","author":"Tobin","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2024.05.046_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jmedgenet-2019-106461","article-title":"Investigating the genetic susceptibility to exertional heat illness","volume":"57","author":"Gardner","year":"2020","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.bja.2024.05.046_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40279-021-01569-9","article-title":"Comment on \u201cOverlapping Mechanisms of Exertional Heat Stroke and Malignant Hyperthermia: Evidence vs. Conjecture\u201d","volume":"52","author":"van den Bersselaar","year":"2022","journal-title":"Sports Med"},{"key":"10.1016\/j.bja.2024.05.046_bib26","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4085\/1062-6050-50.12.01","article-title":"Exertional heat stroke and susceptibility to malignant hyperthermia in an athlete: evidence for a link?","volume":"50","author":"Poussel","year":"2015","journal-title":"J\u00a0Athl Train"},{"key":"10.1016\/j.bja.2024.05.046_bib27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/bja\/aew047","article-title":"Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in\u00a0vitro contracture test","volume":"116","author":"Roux-Buisson","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135496","article-title":"Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?","volume":"10","author":"Sagui","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bja.2024.05.046_bib29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jsams.2018.11.012","article-title":"Thermoregulation and markers of muscle breakdown in malignant hyperthermia susceptible volunteers during an acute heat tolerance test","volume":"22","author":"House","year":"2019","journal-title":"J\u00a0Sci Med Sport"},{"key":"10.1016\/j.bja.2024.05.046_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1152\/japplphysiol.01003.2020","article-title":"The effect of statins on RyR and RyR-associated disease","volume":"131","author":"Haseeb","year":"2021","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.bja.2024.05.046_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00228-014-1776-9","article-title":"Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives","volume":"71","author":"Hedenmalm","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bja.2024.05.046_bib32","first-page":"541","article-title":"Muscle ultrasound abnormalities in individuals with RYR1-related malignant hyperthermia susceptibility","volume":"10","author":"van den Bersselaar","year":"2023","journal-title":"J\u00a0Neuromuscul Dis"},{"key":"10.1016\/j.bja.2024.05.046_bib33","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.bja.2018.09.014","article-title":"Is malignant hyperthermia associated with hyperglycaemia?","volume":"122","author":"Altamirano","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nmd.2023.09.003","article-title":"Pancreatitis in RYR1-related disorders","volume":"33","author":"Famili","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2024.05.046_bib35","doi-asserted-by":"crossref","first-page":"ra68","DOI":"10.1126\/scisignal.aad9813","article-title":"An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities","volume":"9","author":"Lopez","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.bja.2024.05.046_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53999","article-title":"Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes","volume":"9","author":"Tammineni","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.bja.2024.05.046_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78874","article-title":"Muscle calcium stress cleaves junctophilin1, unleashing a gene regulatory program predicted to correct glucose dysregulation","volume":"12","author":"Tammineni","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.bja.2024.05.046_bib38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s12630-020-01895-y","article-title":"Untargeted metabolomics profiling of skeletal muscle samples from malignant hyperthermia susceptible patients","volume":"68","author":"Bojko","year":"2021","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib39","first-page":"876","article-title":"The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations","volume":"266","author":"Knuiman","year":"2019","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.bja.2024.05.046_bib40","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.05.046_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.nmd.2018.10.006","article-title":"Functional impairments, fatigue and quality of life in RYR1-related myopathies: a questionnaire study","volume":"29","author":"van Ruitenbeek","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2024.05.046_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4085\/1062-6050-52.2.06","article-title":"Round table on malignant hyperthermia in physically active populations: meeting proceedings","volume":"52","author":"Hosokawa","year":"2017","journal-title":"J\u00a0Athl Train"},{"key":"10.1016\/j.bja.2024.05.046_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/ALN.0b013e3181c29504","article-title":"Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel \u03b1-1 subunit gene, and calsequestrin-1 gene polymorphisms","volume":"112","author":"Capacchione","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.05.046_bib45","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12630-019-01320-z","article-title":"Fatal awake malignant hyperthermia episodes in a family with malignant hyperthermia susceptibility: a case series","volume":"66","author":"Zvaritch","year":"2019","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib46","first-page":"23","article-title":"Improving awareness of nonanesthesia-related malignant hyperthermia presentations: a tale of two brothers","volume":"3","author":"Potts","year":"2014","journal-title":"A\u00a0A Case Rep"},{"key":"10.1016\/j.bja.2024.05.046_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.34024\/rnc.2021.v29.12345","article-title":"Elabora\u00e7\u00e3o De Manual De Orienta\u00e7\u00f5es Sobre Hipertermia Maligna Para Pacientes","volume":"29","author":"Rodrigues","year":"2021","journal-title":"Rev Neurocienc"},{"key":"10.1016\/j.bja.2024.05.046_bib48","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/ALN.0000000000004199","article-title":"Referral indications for malignant hyperthermia susceptibility diagnostics in patients without adverse anesthetic events in the era of next-generation sequencing","volume":"136","author":"van den Bersselaar","year":"2022","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.05.046_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000542-200101000-00019","article-title":"Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis","volume":"94","author":"Wappler","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.05.046_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-6576.1983.tb01966.x","article-title":"Studies of body temperatures, blood lactate, cortisol and free fatty acid levels during exercise in human subjects susceptible to malignant hyperpyrexia","volume":"27","author":"Campbell","year":"1983","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bja.2024.05.046_bib51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1213\/ANE.0000000000002232","article-title":"Skeletal muscle metabolic dysfunction in patients with malignant hyperthermia susceptibility","volume":"125","author":"Thompson","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.05.046_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0750-7658(89)80008-5","article-title":"Conduite \u00e0 tenir devant un sujet susceptible de pr\u00e9senter une hyperthermie maligne en cas d'anesth\u00e9sie et dans la vie quotidienne","volume":"8","author":"Jacquot","year":"1989","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.bja.2024.05.046_bib53","doi-asserted-by":"crossref","first-page":"e1854","DOI":"10.7205\/MILMED-D-16-00186","article-title":"Malignant hyperthermia susceptibility and fitness for duty","volume":"182","author":"Lee","year":"2017","journal-title":"Mil Med"},{"key":"10.1016\/j.bja.2024.05.046_bib54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(76)90120-5","article-title":"The effects of dantrolene sodium on cardiac and skeletal muscle in rats","volume":"39","author":"Meyler","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bja.2024.05.046_bib55","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2011.12.003","article-title":"182nd ENMC International Workshop: RYR1-related myopathies, 15\u201317th April 2011, Naarden, The Netherlands","volume":"22","author":"Jungbluth","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2024.05.046_bib56","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1152\/japplphysiol.00319.2015","article-title":"Mechanisms underlying enhancements in muscle force and power output during maximal cycle ergometer exercise induced by chronic \u03b22-adrenergic stimulation in men","volume":"119","author":"Hostrup","year":"2015","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.bja.2024.05.046_bib57","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2004-821173","article-title":"Pilot trial of salbutamol in central core and multi-minicore diseases","volume":"35","author":"Messina","year":"2004","journal-title":"Neuropediatrics"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.bja.2024.05.046_bib58","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1007\/s10545-010-9085-7","article-title":"Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction","volume":"33","author":"Schreuder","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.bja.2024.05.046_bib59","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1042\/BCJ20170282","article-title":"Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease","volume":"474","author":"Chen","year":"2017","journal-title":"Biochem J"},{"key":"10.1016\/j.bja.2024.05.046_bib60","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1089\/ars.2005.7.870","article-title":"Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels","volume":"7","author":"Aracena","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bja.2024.05.046_bib61","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1074\/jbc.M607590200","article-title":"Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein","volume":"282","author":"Zissimopoulos","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bja.2024.05.046_bib62","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/aws036","article-title":"Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy","volume":"135","author":"Dowling","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bja.2024.05.046_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","article-title":"RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knock-in mice","volume":"133","author":"Durham","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bja.2024.05.046_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6792694","article-title":"Antioxidant treatment reduces formation of structural cores and improves muscle function in RYR1Y522S\/WT mice","volume":"2017","author":"Michelucci","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.bja.2024.05.046_bib65","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1212\/WNL.0000000000008872","article-title":"Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies","volume":"94","author":"Todd","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.bja.2024.05.046_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bja.2018.08.009","article-title":"Abnormal calcium signalling and the caffeine-halothane contracture test","volume":"122","author":"Figueroa","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.05.046_bib67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1085\/jgp.201812152","article-title":"SR Ca2+ leak in skeletal muscle fibers acts as an intracellular signal to increase fatigue resistance","volume":"151","author":"Ivarsson","year":"2019","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.bja.2024.05.046_bib68","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.1073\/pnas.1507176112","article-title":"Ryanodine receptor fragmentation and sarcoplasmic reticulum Ca2+ leak after one session of high-intensity interval exercise","volume":"112","author":"Place","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2024.05.046_bib69","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1038\/s41467-021-27422-1","article-title":"Acute RyR1 Ca2+ leak enhances NADH-linked mitochondrial respiratory capacity","volume":"12","author":"Zanou","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2024.05.046_bib70","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1203\/00006450-200212000-00004","article-title":"Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking","volume":"52","author":"Perlmutter","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bja.2024.05.046_bib71","article-title":"A\u00a0chemical chaperone improves muscle function in mice with a RyR1 mutation","volume":"8","author":"Lee","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2024.05.046_bib72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1872208311206030157","article-title":"Ryanodine receptor patents","volume":"6","author":"Kushnir","year":"2012","journal-title":"Recent Pat Biotechnol"},{"key":"10.1016\/j.bja.2024.05.046_bib73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrd2857","article-title":"Fixing the leak","volume":"8","author":"Crunkhorn","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bja.2024.05.046_bib74","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00401-020-02150-w","article-title":"Intracellular calcium leak as a therapeutic target for RYR1-related myopathies","volume":"139","author":"Kushnir","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bja.2024.05.046_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102433","article-title":"Rycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial","volume":"68","author":"Todd","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.bja.2024.05.046_bib76","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1038\/s41467-021-24644-1","article-title":"A\u00a0novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke","volume":"12","author":"Yamazawa","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2024.05.046_bib77","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?","volume":"229","author":"Corton","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bja.2024.05.046_bib78","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nm.2598","article-title":"AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation","volume":"18","author":"Lanner","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.bja.2024.05.046_bib79","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52946","article-title":"Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline","volume":"9","author":"Volpatti","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.bja.2024.05.046_bib80","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1242\/dev.004531","article-title":"Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease","volume":"134","author":"Hirata","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.bja.2024.05.046_bib81","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1124\/mol.117.111468","article-title":"Efficient high-throughput screening by endoplasmic reticulum Ca2+ measurement to identify inhibitors of ryanodine receptor Ca2+-release channels","volume":"94","author":"Murayama","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bja.2024.05.046_bib82","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13311-018-00677-1","article-title":"Ryanodine receptor 1-related myopathies: diagnostic and therapeutic approaches","volume":"15","author":"Lawal","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bja.2024.05.046_bib83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1389201022666210910102516","article-title":"Therapies for RYR1-related myopathies: where we stand and the perspectives","volume":"28","author":"Beaufils","year":"2022","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bja.2024.05.046_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hgtb.2015.140","article-title":"Expressing transgenes that exceed the packaging capacity of adeno-associated virus capsids","volume":"27","author":"Chamberlain","year":"2016","journal-title":"Hum Gene Ther Methods"},{"key":"10.1016\/j.bja.2024.05.046_bib85","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/hum.2013.052","article-title":"Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy","volume":"24","author":"Rendu","year":"2013","journal-title":"Hum Gene Ther"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224004197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224004197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T17:06:46Z","timestamp":1726765606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091224004197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0007091224004197"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2024.05.046","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2024.05.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}